Islet Cell Carcinoma
6 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine Carcinomas (NCT03042780) | H. Lee Moffitt Cancer Center and Research Institute | 2017-02-01 |
| Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors (NCT01824875) | ECOG-ACRIN Cancer Research Group | 2013-08-08 |
| Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy (NCT00363051) | Novartis Pharmaceuticals | 2006-06-01 |
| RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma (NCT00113360) | M.D. Anderson Cancer Center | 2005-01-01 |
| Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors (NCT00227773) | Eastern Cooperative Oncology Group | |
| Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy (NCT00003514) | Burzynski Research Institute |
Track Islet Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.